FDA: The Effects of Loper on the Regulatory Agenda
Foley – Regulations enacted by the FDA via notice-and-comment rulemaking will no longer be subject to the deference accorded by Chevron.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year